Downregulation of PGM5 expression correlates with tumor progression and poor prognosis in human prostate cancer

Downregulation of PGM5 expression correlates with tumor progression and poor prognosis in human prostate cancer

Abstract Prostate cancer (PCa) is the most common malignancy in men in developed countries. Prostate-specific antigen (PSA) remains the most widely used serum marker for prostate cancer. Here, we reported that the expression of phosphoglucomutase-like protein 5 (PGM5) is significantly lower in prost...

Full description

Bibliographic Details
Main Authors: Jian Sun, Fei Wang, Huihui Zhou, Chunchun Zhao, Kai Li, Caibin Fan, Jianqing Wang
Format: Article
Language:English
Published: Springer 2022-07-01
Series:Discover Oncology
Subjects:
Prostate cancer
PGM5
Prognostic marker
Bioinformatics analysis
Online Access:https://doi.org/10.1007/s12672-022-00525-x

Similar Items

Similar Items